Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-011971
Filing Date
2025-08-14
Accepted
2025-08-14 16:01:14
Documents
68
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1370565
2 EX-10.8 ex10-8.htm EX-10.8 13667
3 EX-31.1 ex31-1.htm EX-31.1 11594
4 EX-31.2 ex31-2.htm EX-31.2 11493
5 EX-32.1 ex32-1.htm EX-32.1 4621
6 EX-32.2 ex32-2.htm EX-32.2 4250
7 GRAPHIC form10-q_001.jpg GRAPHIC 210159
8 GRAPHIC form10-q_002.jpg GRAPHIC 67927
9 GRAPHIC form10-q_003.jpg GRAPHIC 15073
10 GRAPHIC form10-q_004.jpg GRAPHIC 36616
11 GRAPHIC form10-q_005.jpg GRAPHIC 40352
12 GRAPHIC form10-q_006.jpg GRAPHIC 12417
  Complete submission text file 0001493152-25-011971.txt   7489173

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE gtbp-20250630.xsd EX-101.SCH 46456
14 XBRL CALCULATION FILE gtbp-20250630_cal.xml EX-101.CAL 37703
15 XBRL DEFINITION FILE gtbp-20250630_def.xml EX-101.DEF 227542
16 XBRL LABEL FILE gtbp-20250630_lab.xml EX-101.LAB 419016
17 XBRL PRESENTATION FILE gtbp-20250630_pre.xml EX-101.PRE 337480
70 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1006397
Mailing Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111
Business Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40023 | Film No.: 251218435
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)